Clinical translation of nanomedicine
Clinical Translation of Nanomedicine | Chemical Reviews ACS ACS Publications C&EN CAS
Find my institution Log In Chemical Reviews ACS Publications. Most Trusted. Most Cited. Most …
Find my institution Log In Chemical Reviews ACS Publications. Most Trusted. Most Cited. Most …
[HTML][HTML] Lung cancer: current diagnosis and treatment
S Hammerschmidt, H Wirtz - Deutsches Ärzteblatt International, 2009 - ncbi.nlm.nih.gov
Background Much progress has been made in the treatment of lung cancer in the last ten
years (adjuvant chemotherapy, targeted therapy, individualized therapy). Nonetheless, lung …
years (adjuvant chemotherapy, targeted therapy, individualized therapy). Nonetheless, lung …
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non …
MA Socinski, I Bondarenko, NA Karaseva… - Journal of Clinical …, 2012 - ascopubs.org
Purpose This phase III trial compared the efficacy and safety of albumin-bound paclitaxel
(nab-paclitaxel) plus carboplatin with solvent-based paclitaxel (sb-paclitaxel) plus …
(nab-paclitaxel) plus carboplatin with solvent-based paclitaxel (sb-paclitaxel) plus …
[HTML][HTML] Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study
D De Ruysscher, A Botterweck, M Dirx… - Annals of oncology, 2009 - Elsevier
Background: Patients with stage III non-small-cell lung cancer (NSCLC) and limited disease
small-cell lung cancer are excluded from concurrent chemoradiation mostly on the basis of …
small-cell lung cancer are excluded from concurrent chemoradiation mostly on the basis of …
[HTML][HTML] Nodal upstaging is more common with thoracotomy than with VATS during lobectomy for early-stage lung cancer: an analysis from the National Cancer Data …
Introduction Questions remain regarding differences in nodal evaluation and upstaging
between thoracotomy (open) and video-assisted thoracic surgery (VATS) approaches to …
between thoracotomy (open) and video-assisted thoracic surgery (VATS) approaches to …
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent
J Zhu, Y Yuan, X Wan, D Yin, R Li… - Cochrane Database …, 2021 - cochranelibrary.com
Background Non‐small cell lung cancer (NSCLC) is the most common lung cancer,
accounting for approximately 80% to 85% of all cases. For people with localised NSCLC …
accounting for approximately 80% to 85% of all cases. For people with localised NSCLC …
[HTML][HTML] A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimen
PURPOSE: To assess the clinical relevance of a semiautomatic CT-based ensemble
segmentation method, by comparing it to pathology and to CT/PET manual delineations by …
segmentation method, by comparing it to pathology and to CT/PET manual delineations by …
Results of primary surgery with t4 non–small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk
B Yıldızeli, PG Dartevelle, E Fadel, S Mussot… - The Annals of thoracic …, 2008 - Elsevier
BACKGROUND: The purpose of this study was to assess operative mortality, morbidity, and
long-term results of patients with surgically resected T4 non–small cell lung carcinoma …
long-term results of patients with surgically resected T4 non–small cell lung carcinoma …
Comparison of the automatic segmentation of multiple organs at risk in CT images of lung cancer between deep convolutional neural network-based and atlas-based …
J Zhu, J Zhang, B Qiu, Y Liu, X Liu, L Chen - Acta Oncologica, 2019 - Taylor & Francis
Background: In this study, a deep convolutional neural network (CNN)-based automatic
segmentation technique was applied to multiple organs at risk (OARs) depicted in computed …
segmentation technique was applied to multiple organs at risk (OARs) depicted in computed …
Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism
Purpose: Cancer cells (relative to normal cells) show increased steady-state levels of
hydroperoxides that are compensated by increased glucose and hydroperoxide metabolism …
hydroperoxides that are compensated by increased glucose and hydroperoxide metabolism …